Tata Chemicals’ under-construction nutraceuticals plant in Chennai is expected to go on-stream in December 2013. “We aim to begin the trial run at the plant in next two months and the plant should start commercial production by December 2013,” said R Mukundan, Managing Director, Tata Chemicals Ltd, at a recently held press conference for announcing the company’s Q1 FY2013-14 results.
The company is investing about Rs 50 crore for the new plant, which will manufacture oligosaccharides initially. With this plant, the company will foray into the burgeoning nutraceuticals market, which is gaining traction as consumers are becoming increasingly health conscious.
As part of its growth strategy, Tata Chemicals is focusing on building its specialty chemicals and consumer business portfolio. And nutraceutical venture is a part of this strategy.
The company is investing about Rs 50 crore for the new plant, which will manufacture oligosaccharides initially. With this plant, the company will foray into the burgeoning nutraceuticals market, which is gaining traction as consumers are becoming increasingly health conscious.
As part of its growth strategy, Tata Chemicals is focusing on building its specialty chemicals and consumer business portfolio. And nutraceutical venture is a part of this strategy.